Matthias J Schnell Selected Research

Matthias J Schnell Research Topics

25	Rabies (Hydrophobia) 01/2022 - 04/2002
19	Infections 01/2019 - 01/2002
12	Vesicular Stomatitis 07/2021 - 04/2003
8	Communicable Diseases (Infectious Diseases) 01/2022 - 04/2003
5	Virus Diseases (Viral Diseases) 12/2016 - 01/2002
4	COVID-19 01/2022 - 01/2020
3	Weight Loss (Weight Reduction) 01/2022 - 01/2015
3	Neoplasms (Cancer) 05/2015 - 07/2008
3	Neuroblastoma 01/2011 - 12/2005
2	Inflammation (Inflammations) 01/2022 - 12/2005
2	Lung Diseases (Lung Disease) 01/2022 - 01/2021
2	Lassa Fever (Fever, Lassa) 01/2021 - 10/2018
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2020 - 01/2017
2	Anthrax 08/2010 - 09/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2009 - 04/2007
2	Neoplasm Metastasis (Metastasis) 04/2009 - 07/2008
2	Colorectal Neoplasms (Colorectal Cancer) 04/2009 - 07/2008
2	Hepatitis C 01/2003 - 01/2002
1	Measles 04/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Asymptomatic Infections 01/2021
1	Marburg Virus Disease 01/2019
1	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 10/2018
1	Zoonoses 01/2017
1	Henipavirus Infections 01/2015
1	Fever (Fevers) 07/2014
1	Central Nervous System Diseases (CNS Diseases) 01/2012
1	Intestinal Neoplasms (Intestinal Cancer) 04/2009
1	Colonic Neoplasms (Colon Cancer) 04/2009
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2009
1	Carcinogenesis 04/2009

40	VaccinesIBA 04/2022 - 01/2002
10	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2002
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2003
5	Neutralizing AntibodiesIBA 01/2022 - 12/2009
5	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2003
4	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 12/2006
4	AntigensIBA 01/2019 - 09/2006
3	AntibodiesIBA 04/2022 - 11/2008
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 06/2003
3	Combined VaccinesIBA 01/2017 - 10/2011
2	COVID-19 VaccinesIBA 01/2022 - 01/2020
2	SARS-CoV-2 spike proteinIBA 01/2022 - 07/2021
2	CoraVax COVID-19 vaccineIBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2020 - 11/2008
2	Ebola VaccinesIBA 01/2019 - 02/2015
2	Rabies Vaccines (Rabies Vaccine)FDA Link 10/2018 - 06/2003
2	Codon (Codons)IBA 01/2015 - 01/2011
2	Inactivated VaccinesIBA 10/2011 - 06/2004
2	Interferon Type IIBA 07/2010 - 12/2009
2	Enterotoxin ReceptorsIBA 04/2009 - 07/2008
2	Viral RNAIBA 11/2008 - 07/2007
1	Pharmaceutical PreparationsIBA 01/2020
1	Molecular Probes (Molecular Probe)IBA 01/2020
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2017
1	Attenuated VaccinesIBA 05/2015
1	InflammasomesIBA 05/2013
1	Viral AntigensIBA 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2011
1	Pattern Recognition ReceptorsIBA 07/2010
1	Immunotoxins (Immunotoxin)IBA 02/2010
1	SilverIBA 06/2009
1	AutoantigensIBA 04/2009
1	Viral VaccinesIBA 11/2008
1	A-factor (Streptomyces)IBA 04/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005
1	Chemokine CCL5IBA 01/2002

3	Therapeutics 05/2015 - 06/2003
2	Immunotherapy 04/2009 - 07/2008